{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:02:56Z","timestamp":1790683376738,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00188","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T05:04:00Z","timestamp":1557810240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal"],"prefix":"10.3389","volume":"7","author":[{"given":"Manon","family":"Tauzin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Durrmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Dassieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Barre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Caeymaex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00431-014-2279-5","article-title":"Current management of late onset neonatal bacterial sepsis in five European countries","volume":"173","author":"Lutsar","year":"2014","journal-title":"Eur J Pediatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/jac\/dks495","article-title":"The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties","volume":"68","author":"Vandecasteele","year":"2013","journal-title":"J Antimicrob Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s10096-018-3277-8","article-title":"Factors impacting unbound vancomycin concentrations in neonates and young infants","volume":"37","author":"Smits","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2165\/00003088-200443070-00001","article-title":"Vancomycin: pharmacokinetics and administration regimens in neonates","volume":"43","author":"de Hoog","year":"2004","journal-title":"Clin Pharmacokinet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.6061\/clinics\/2012(07)21","article-title":"Clinical pharmacokinetics of vancomycin in the neonate: a review","volume":"67","author":"Pacifici","year":"2012","journal-title":"Clin S\u00e3o Paulo Braz."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1128\/AAC.03620-14","article-title":"Association between vancomycin trough concentration and area under the concentration-time curve in neonates","volume":"58","author":"Frymoyer","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"key":"B8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1586\/17512433.2015.1060124","article-title":"How to use vancomycin optimally in neonates: remaining questions","volume":"8","author":"Jacqz-Aigrain","year":"2015","journal-title":"Expert Rev Clin Pharmacol."},{"key":"B9","unstructured":"2017"},{"key":"B10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/jac\/dkv451","article-title":"Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates","volume":"71","author":"Ramos-Mart\u00edn","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.arcped.2016.06.002","article-title":"Posologie des antibiotiques chez le nouveau-n\u00e9: variations des pratiques et comment y rem\u00e9dier e","volume":"23","author":"Leroux","year":"2016","journal-title":"Arch P\u00e9diatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/INF.0000000000000244","article-title":"Commentary: continuous infusion of vancomycin in neonates: to use or not to use remains the question","volume":"33","author":"Ward","year":"2014","journal-title":"Pediatr Infect Dis J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/jac\/dks510","article-title":"Stability and compatibility of vancomycin for administration by continuous infusion","volume":"68","author":"Raverdy","year":"2013","journal-title":"J Antimicrob Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1651-2227.2011.02547.x","article-title":"Evidence-based approach to preventing central line-associated bloodstream infection in the NICU: evidence-based approach to preventing NICU CLABSI","volume":"101","author":"Stevens","year":"2012","journal-title":"Acta Paediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/archdischild-2012-303197","article-title":"Continuous infusion of vancomycin in neonates","volume":"98","author":"Patel","year":"2013","journal-title":"Arch Dis Child."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1128\/AAC.01718-13","article-title":"Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations","volume":"58","author":"Kim","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcrc.2012.02.003","article-title":"Continuous intravenous administration of vancomycin in medical intensive care unit patients","volume":"28","author":"Saugel","year":"2013","journal-title":"J Crit Care."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1128\/AAC.45.9.2460-2467.2001","article-title":"Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study","volume":"45","author":"Wysocki","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/jcpt.12270","article-title":"The pharmacokinetic\/pharmacodynamic rationale for administering vancomycin via continuous infusion","volume":"40","author":"Waineo","year":"2015","journal-title":"J Clin Pharm Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/archdischild-2012-302765","article-title":"Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring","volume":"98","author":"Zhao","year":"2013","journal-title":"Arch Dis Child."},{"key":"B21","doi-asserted-by":"publisher","first-page":"F365","DOI":"10.1136\/adc.2010.196402","article-title":"Vancomycin prescription in neonates and young infants: toward a simplified dosage","volume":"96","author":"Oudin","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet Lond Engl."},{"key":"B23","first-page":"17","article-title":"Vancomycin pharmacokinetics in premature infants","volume":"5","author":"Gross","year":"1985","journal-title":"Pediatr Pharmacol N Y N."},{"key":"B24","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/pch\/19.6.e30","article-title":"Assessment of initial vancomycin dosing in neonates","volume":"19","author":"Dersch-Mills","year":"2014","journal-title":"Paediatr Child Health."},{"key":"B25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cca.2008.06.017","article-title":"Establishing age\/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods","volume":"396","author":"Pottel","year":"2008","journal-title":"Clin Chim Acta."},{"key":"B26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2125.1998.00763.x","article-title":"Constant rate infusion of vancomycin in premature neonates: a new dosage schedule","volume":"46","author":"Pawlotsky","year":"1998","journal-title":"Br J Clin Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"F418","DOI":"10.1136\/adc.2007.128280","article-title":"Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule","volume":"93","author":"Plan","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1128\/AAC.01968-15","article-title":"Towards rational dosing algorithms for vancomycin in neonates and infants based on population pharmacokinetic modeling","volume":"60","author":"Janssen","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1128\/AAC.02214-15","article-title":"Clinical utility and safety of a model-based patient-tailored dose of vancomycin in neonates","volume":"60","author":"Leroux","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/j.1365-2125.2012.04406.x","article-title":"External evaluation of population pharmacokinetic models of vancomycin in neonates: transferability of published vancomycin population pharmacokinetic models in neonates","volume":"75","author":"Zhao","year":"2013","journal-title":"Br J Clin Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/s12879-014-0582-4","article-title":"Clinical and molecular characteristics of invasive community-acquired Staphylococcus aureus infections in Chinese children","volume":"14","author":"Qiao","year":"2014","journal-title":"BMC Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1542\/peds.2004-0043","article-title":"Features of invasive staphylococcal disease in neonates","volume":"114","author":"Healy","year":"2004","journal-title":"Pediatrics."},{"key":"B33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12887-016-0753-0","article-title":"Coagulase negative Staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?","volume":"16","author":"Padari","year":"2016","journal-title":"BMC Pediatr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/600884","article-title":"Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients","volume":"49","author":"Lodise","year":"2009","journal-title":"Clin Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/jac\/dkn080","article-title":"Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy","volume":"62","author":"Ingram","year":"2008","journal-title":"J Antimicrob Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1097\/INF.0b013e318286378e","article-title":"Improved vancomycin dosing in children using area under the curve exposure","volume":"32","author":"Le","year":"2013","journal-title":"Pediatr Infect Dis J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/AAC.01653-13","article-title":"Are vancomycin trough concentrations adequate for optimal dosing?","volume":"58","author":"Neely","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/QCO.0000000000000263","article-title":"Vancomycin toxicity in neonates: a review of the evidence","volume":"29","author":"Lestner","year":"2016","journal-title":"Curr Opin Infect Dis."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T05:04:03Z","timestamp":1557810243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":38,"alternative-id":["10.3389\/fped.2019.00188"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00188","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"article-number":"188"}}